# Neuro-Oncology

Source: https://onco.cc/journals/neuro-oncology/  
OnCo record `neuro-oncology` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Neuro-Oncology is the Society for Neuro-Oncology's journal, publishing glioma, brain metastasis and paediatric brain tumour research, response criteria and the CBTRUS statistical reports.

## Summary

Publishes the annual CBTRUS statistical report on US brain tumours, the RANO response-assessment criteria, molecular classification work that feeds the WHO CNS tumour classification, and phase 2 trials in glioma. Hybrid access via Oxford University Press; the SNO annual meeting abstracts appear as a supplement.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: Neuro Oncol
- Publisher: Oxford University Press
- Scope: neuro-oncology
- Access: hybrid

## Sources

- Society for Neuro-Oncology: https://www.soc-neuro-onc.org

## Connected records

- cancers: [Glioma & glioblastoma](https://onco.cc/cancers/glioblastoma/)
- people: [Patrick Y. Wen](https://onco.cc/people/patrick-wen/)
- key papers: [A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma](https://onco.cc/key-papers/paper-carboplatin-glioblastoma-neuro-oncol-2003/), [ACNS1123: response-based reduced-dose whole-ventricular radiotherapy for localised germinoma](https://onco.cc/key-papers/paper-acns1123-germinoma-neuro-oncology-2022/), [Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors](https://onco.cc/key-papers/paper-fruhwald-neuro-oncol/), [EANO guideline on the diagnosis and management of meningiomas (2021)](https://onco.cc/key-papers/paper-eano-meningioma-goldbrunner-neuro-oncology-2021/), [Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions](https://onco.cc/key-papers/paper-andrew-lassman-neuro-oncol-2020/), [Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter](https://onco.cc/key-papers/paper-lim-neuro-oncol/), [Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group](https://onco.cc/key-papers/paper-karschnia-neuro-oncol/), [Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial](https://onco.cc/key-papers/paper-omuro-neuro-oncol/), [Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma](https://onco.cc/key-papers/paper-carboplatin-glioblastoma-neuro-oncol-2015/), [SIOP CNS GCT 96: outcomes for children and adults with intracranial germinoma treated with radiotherapy alone or chemotherapy plus reduced radiotherapy](https://onco.cc/key-papers/paper-siop-cns-gct-96-calaminus-neuro-oncology-2013/), [The 2021 WHO classification of tumours of the central nervous system: a summary](https://onco.cc/key-papers/paper-who-2021-cns-louis-neuro-oncology-2021/)
- journals: [Journal of neuro-oncology](https://onco.cc/journals/journal-of-neuro-oncology/)

---
JSON: https://onco.cc/api/v1/entities/neuro-oncology.json